Modalis Therapeutics (4883.TSE) Q3 2024 Earnings

7AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-15
-12
-10
-8

Details

Expected EPS
N/A
Actual EPS
-8
Surprise EPS
-8
Surprise Percent
+∞%

Description

Modalis Therapeutics (4883.TSE) has reported earnings of -8 per share for Q3 2024.

0 Comments

Share your thoughts